Company profile
Symbiosis Pharmaceutical Services | Global Biologics CMO
Symbiosis Pharma is a biologics CMO offering rapid access to aseptic fill finish manufacturing slots across vaccines, ATMPs, mAbs & more
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNzkyODk5MWFkaXF6a2N4 | Paper/PDF filed
Published 03 Oct 2024 06:26
Company registered at Companies House
1 Nov 2018 to 31 Oct 2021
"The rapid development of novel treatments called Advanced Therapies, such as cell therapies and gene therapies have required new manufacturing facilities and technologies worldwide. Manufacturing of gene therapy viral vectors for human use requires specialised high-quality manufacturing facilities and there is currently insufficient such capacity in the ...
1 Dec 2017 to 31 Mar 2019
Cell and gene therapy products are changing the lives of patients receiving treatment as part of early stage clinical trials. There is a clear need for a flexible rapid approach to the production of viral vector material to support both clinical trials and in-market supply for these innovative Gene Therapy products in order to rapidly treat patients. This...
